TrialInternational journal of hematology2017
NKG2D gene polymorphisms are associated with disease control of chronic myeloid leukemia by dasatinib.
Ryujiro Hara et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papercites it